Latest Us Government Engagement News

Resolution Minerals has turned Horse Heaven into the centre of its strategy, pairing broad gold drilling with high-grade antimony and tungsten test work. The expansion came with a sharply higher A$53.3 million FY2026 loss and a disclosed dependence on future funding.

American Tungsten & Antimony has started an ahead-of-schedule campaign to produce antimony flake at its Del Sol refinery in Nevada, using material from Arizona. The first physical demonstration of its proposed US mine-to-metal chain could generate samples for customer qualification and government discussions, although the underlying asset acquisition remains incomplete.

Island Pharmaceuticals is accelerating development of its broad-spectrum antiviral Galidesivir, progressing clinical, regulatory, and manufacturing milestones under the FDA Animal Rule pathway with expanded USAMRIID collaboration and biodefence positioning.

American West Metals has reported exceptional assay results from resampling historical drill core at its West Desert Project in Utah, revealing high-grade indium, copper, zinc, silver, and lead. The new data expands known mineralised intervals and supports ongoing drilling and government engagement.

Anson Resources' US arm, A1 Lithium, secures membership in a key US defense consortium, boosting government ties and funding prospects. Its Yellow Cat project earns a positive technical feasibility rating, aligning with US critical minerals priorities.

American West Metals reported a 20% increase in contained copper at its Storm Copper Project and intersected promising skarn mineralisation in initial West Desert drilling, highlighting significant exploration upside across its North American base metals portfolio.

BluGlass Limited reported a 14% revenue increase to A$5.76 million and a 28% reduction in net loss to A$4.1 million for H1 FY26, bolstered by a key US Department of War contract extension and a refreshed board driving growth.

Island Pharmaceuticals reports a 213.8% increase in half-year loss to $4.81 million, driven by strategic acquisition and clinical development investments. The company advances its antiviral portfolio with Galidesivir and ISLA-101, supported by strong US regulatory engagement and a $9 million capital raise.

American West Metals has appointed a top Washington DC advisory firm to deepen US government engagement for its West Desert Project, aiming to establish the first domestic indium supply chain amid critical minerals supply risks.

Sovereign Metals has successfully recovered a high-value heavy rare earth concentrate from its Kasiya project in Malawi, while securing a strategic collaboration with the World Bank’s IFC to underpin sustainable development and financing.

St George Mining has appointed a top Washington DC government relations firm to deepen its engagement with US agencies, advancing its Araxá rare earths project amid growing US efforts to secure critical mineral supply chains in the Western Hemisphere.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.